HUA-SHENG CHIU to Treatment Outcome
This is a "connection" page, showing publications HUA-SHENG CHIU has written about Treatment Outcome.
Connection Strength
0.018
-
Early Therapeutic Drug Monitoring Optimizes Teicoplanin Use in Febrile Neutropenic Patients with Hematological Malignancies. Adv Ther. 2024 Jul; 41(7):2966-2977.
Score: 0.018